INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

IHL	Name Change Notification		02/07/20	135.17KB	Share
IHL	Appendix 2A		01/07/20	121.37KB	Share
IHL	Cleansing Notice		01/07/20	144.38KB	Share
IHL	Exercise of Options		30/06/20	119.92KB	Share
IHL	Appendix 2A		29/06/20	126.68KB	Share
IHL	Cleansing Notice		29/06/20	144.23KB	Share
IHL	Proposed issue of Securities - IHL		26/06/20	29.23KB	Share
IHL	Results of EGM		26/06/20	456.85KB	Share
IHL	EGM COVID-19 Social Distancing Measures		25/06/20	440.31KB	Share
IHL	Exercise of Options		10/06/20	118.83KB	Share
IHL	Oral Devices and Cannabinoid Sales Update	PRICE SENSITIVE	03/06/20	155.58KB	Share
IHL	IHL commences IHL-675 (ARDS) animal study	PRICE SENSITIVE	02/06/20	171.21KB	Share
IHL	Options Exercise		01/06/20	303.83KB	Share
IHL	Notice of Shareholder Meeting and Proxy Form		26/05/20	858.18KB	Share
IHL	NRL player James Graham joins Impression TBI program	PRICE SENSITIVE	19/05/20	155.07KB	Share
IHL	Resubmission Appendix 4C - ASX new format	PRICE SENSITIVE	15/05/20	295.96KB	Share
IHL	Exercise of Options		04/05/20	118.36KB	Share
IHL	Change in Director's Interest		04/05/20	193.66KB	Share
IHL	Quarterly Update and Appendix 4C	PRICE SENSITIVE	30/04/20	369.66KB	Share
IHL	IHL-216A (TBI/concussion) accelerated FDA approval pathway		23/04/20	1.42MB	Share
IHL	IHL-675A Hydroxychloroquine and CBD for ARDS	PRICE SENSITIVE	15/04/20	242.54KB	Share
IHL	IHL-42x (OSA) accelerated FDA approval pathway	PRICE SENSITIVE	25/03/20	2.36MB	Share
IHL	IHL Acquires CBD Inhalers for Lung Inflammation	PRICE SENSITIVE	19/03/20	166.94KB	Share
IHL	Trading Halt	PRICE SENSITIVE	17/03/20	533.18KB	Share
IHL	Former AFL Footballer Liam Picken Joins Advisory Board		11/03/20	232.31KB	Share
IHL	Clinical Progress on IHL-216A for TBI and CTE	PRICE SENSITIVE	03/03/20	207.75KB	Share
IHL	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	28/02/20	749.43KB	Share
IHL	Appendix 3Y - Change in Director's Interest - Dr Sud Agarwal		14/02/20	194.47KB	Share
IHL	Appendix 2A - Exercise of Options		14/02/20	118.57KB	Share
IHL	Expansion-IncannexTM Cannabinoid Oil Sales Prog/Option Ex.	PRICE SENSITIVE	13/02/20	227.36KB	Share
IHL	RESUBMISSION - Quarterly Update and Appendix 4C	PRICE SENSITIVE	31/01/20	355.53KB	Share
IHL	Quarterly Activities Update and Appendix 4C	PRICE SENSITIVE	31/01/20	355.37KB	Share
IHL	Clinical Progress on IHL-42X for Obstructive Sleep Apnoea	PRICE SENSITIVE	29/01/20	172.54KB	Share
IHL	Change of Share Registry		20/01/20	234.34KB	Share
IHL	Change of Director's Interest Notice		07/01/20	258.52KB	Share
IHL	Appendix 2A		06/01/20	118.82KB	Share
IHL	Impression Sources 1,054 Patients for Incannex CBD-100 Oils		24/12/19	173.45KB	Share
IHL	IHL Files Patent over IHL-42X for OSA	PRICE SENSITIVE	06/12/19	147.98KB	Share
IHL	Appendix 3G		04/12/19	280.22KB	Share
IHL	IHL appoints Big-Pharma expert to lead drug development	PRICE SENSITIVE	04/11/19	241.17KB	Share
IHL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	01/11/19	361.79KB	Share
IHL	Appendix 3B - Placement/Prospectus Securities		31/10/19	444.43KB	Share
IHL	Cleansing Prospectus	PRICE SENSITIVE	24/10/19	400.07KB	Share
IHL	IHL completes $5m capital raise	PRICE SENSITIVE	24/10/19	170.93KB	Share
IHL	Trading Halt	PRICE SENSITIVE	22/10/19	349.14KB	Share
IHL	Conclusion of ONE Championship Agreement		21/10/19	138.14KB	Share
IHL	Results of Meeting		04/10/19	124.35KB	Share
IHL	Incannex Presentation - Dr Sud Agarwal - CMO	PRICE SENSITIVE	04/10/19	6.91MB	Share
IHL	AGM CEO speech		04/10/19	126.94KB	Share
IHL	IHL files cannabinoid patent over IHL-216A for TBI	PRICE SENSITIVE	04/10/19	187.09KB	Share
IHL	Appendix 3B - Exercise of Options		27/09/19	437.81KB	Share
IHL	Appendix 3B		16/09/19	438.07KB	Share
IHL	Retraction of Appendix 3B and 3Y		10/09/19	735.47KB	Share
IHL	Incannex CBD Oils and Medical Advisory Appointees	PRICE SENSITIVE	05/09/19	184.01KB	Share
IHL	AGM Proxy Form		04/09/19	223.63KB	Share
IHL	Notice of Annual General Meeting		04/09/19	351.16KB	Share
IHL	Appendix 3Y		04/09/19	192.82KB	Share
IHL	Appendix 3B		04/09/19	444.5KB	Share
IHL	Corporate Governance Statement - Appendix 4G		04/09/19	195.77KB	Share
IHL	Annual Report to shareholders		04/09/19	1.39MB	Share
IHL	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	30/08/19	1.96MB	Share
IHL	First Key Appointments to Medical Advisory Board		29/08/19	178.56KB	Share
IHL	Major supply agreement - Air Liquide Healthcare	PRICE SENSITIVE	27/08/19	182.53KB	Share
IHL	Change in Directors' Interests - Appendix 3Y x 4		26/08/19	338.79KB	Share
IHL	Appendix 3B		26/08/19	442.63KB	Share
IHL	Cleansing Prospectus		22/08/19	418.92KB	Share
IHL	Appendix 3B - Exercise of Options		22/08/19	435.01KB	Share
IHL	Commencement of Phase 2a Sleep Apnoea Clinical Trial	PRICE SENSITIVE	13/08/19	179.17KB	Share
IHL	Results of Meeting		09/08/19	124.53KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	09/08/19	212.34KB	Share
IHL	Oil Supply Agreement and Brand Launch	PRICE SENSITIVE	09/08/19	282.73KB	Share
IHL	Voluntary Suspension from Official Quotation	PRICE SENSITIVE	08/08/19	349.28KB	Share
IHL	Trading Halt	PRICE SENSITIVE	06/08/19	436.67KB	Share
IHL	Official Supplier and Research Partner - ONE Championship	PRICE SENSITIVE	02/08/19	194.6KB	Share
IHL	Quarterly update and Cashflow Report	PRICE SENSITIVE	31/07/19	370.7KB	Share
IHL	Final Director's Interest Notice - amendment		29/07/19	204.02KB	Share
IHL	Change in Director's Interest Notice x 3		29/07/19	309.76KB	Share
IHL	Dr Sud Agarwal appointed as CMO & Non-Executive Director	PRICE SENSITIVE	25/07/19	157.71KB	Share
IHL	Concussion Monitoring FiTGuard - Major Territory Expansion	PRICE SENSITIVE	17/07/19	537.67KB	Share
IHL	Response to ASX Price Query	PRICE SENSITIVE	15/07/19	405.44KB	Share
IHL	Appendix 3B amendment		11/07/19	128.25KB	Share
IHL	Appendix 3B		11/07/19	411.89KB	Share
IHL	Change in substantial holding		11/07/19	2.49MB	Share
IHL	Notice of General Meeting/Proxy Form		11/07/19	328.71KB	Share
IHL	Update on Placement/Cleansing Prospectus		09/07/19	179.67KB	Share
IHL	Cleansing Prospectus	PRICE SENSITIVE	09/07/19	221.04KB	Share
IHL	Dronabinol Supply Agreement/Sleep Apnoea Trial Update	PRICE SENSITIVE	05/07/19	193.44KB	Share
IHL	Successful $1.65m Placement/International Expansion	PRICE SENSITIVE	03/07/19	213.99KB	Share
IHL	Trading Halt	PRICE SENSITIVE	01/07/19	337.21KB	Share
IHL	Concussion research partner and supplier to Boxing Australia	PRICE SENSITIVE	28/06/19	209.76KB	Share
IHL	Commencement of Phase 2a Periodontitis Clinical Trial	PRICE SENSITIVE	24/06/19	207.63KB	Share
IHL	CEO Comment and Corporate Overview		11/06/19	3.17MB	Share
IHL	Exclusive Concussion Monitoring FitGuard Supply Agreement	PRICE SENSITIVE	06/06/19	770.72KB	Share
IHL	CBD Supply Agreement - Clinical trial Iminent	PRICE SENSITIVE	03/06/19	196.45KB	Share
IHL	Trading Halt	PRICE SENSITIVE	30/05/19	203.91KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	30/05/19	116.99KB	Share
IHL	Appendix 3B		24/05/19	407.78KB	Share
IHL	Reinstatement to Official Quotation	PRICE SENSITIVE	21/05/19	212.57KB	Share
IHL	Company Update - Federal Court Orders	PRICE SENSITIVE	21/05/19	1.61MB	Share
IHL	Update		16/05/19	135.38KB	Share

IHL Name Change Notification
02/07/20		135.17KB	Share
IHL Appendix 2A
01/07/20		121.37KB	Share
IHL Cleansing Notice
01/07/20		144.38KB	Share
IHL Exercise of Options
30/06/20		119.92KB	Share
IHL Appendix 2A
29/06/20		126.68KB	Share
IHL Cleansing Notice
29/06/20		144.23KB	Share
IHL Proposed issue of Securities - IHL
26/06/20		29.23KB	Share
IHL Results of EGM
26/06/20		456.85KB	Share
IHL EGM COVID-19 Social Distancing Measures
25/06/20		440.31KB	Share
IHL Exercise of Options
10/06/20		118.83KB	Share
IHL Oral Devices and Cannabinoid Sales Update
03/06/20	PRICE SENSITIVE	155.58KB	Share
IHL IHL commences IHL-675 (ARDS) animal study
02/06/20	PRICE SENSITIVE	171.21KB	Share
IHL Options Exercise
01/06/20		303.83KB	Share
IHL Notice of Shareholder Meeting and Proxy Form
26/05/20		858.18KB	Share
IHL NRL player James Graham joins Impression TBI program
19/05/20	PRICE SENSITIVE	155.07KB	Share
IHL Resubmission Appendix 4C - ASX new format
15/05/20	PRICE SENSITIVE	295.96KB	Share
IHL Exercise of Options
04/05/20		118.36KB	Share
IHL Change in Director's Interest
04/05/20		193.66KB	Share
IHL Quarterly Update and Appendix 4C
30/04/20	PRICE SENSITIVE	369.66KB	Share
IHL IHL-216A (TBI/concussion) accelerated FDA approval pathway
23/04/20		1.42MB	Share
IHL IHL-675A Hydroxychloroquine and CBD for ARDS
15/04/20	PRICE SENSITIVE	242.54KB	Share
IHL IHL-42x (OSA) accelerated FDA approval pathway
25/03/20	PRICE SENSITIVE	2.36MB	Share
IHL IHL Acquires CBD Inhalers for Lung Inflammation
19/03/20	PRICE SENSITIVE	166.94KB	Share
IHL Trading Halt
17/03/20	PRICE SENSITIVE	533.18KB	Share
IHL Former AFL Footballer Liam Picken Joins Advisory Board
11/03/20		232.31KB	Share
IHL Clinical Progress on IHL-216A for TBI and CTE
03/03/20	PRICE SENSITIVE	207.75KB	Share
IHL Appendix 4D and Half Year Accounts
28/02/20	PRICE SENSITIVE	749.43KB	Share
IHL Appendix 3Y - Change in Director's Interest - Dr Sud Agarwal
14/02/20		194.47KB	Share
IHL Appendix 2A - Exercise of Options
14/02/20		118.57KB	Share
IHL Expansion-IncannexTM Cannabinoid Oil Sales Prog/Option Ex.
13/02/20	PRICE SENSITIVE	227.36KB	Share
IHL RESUBMISSION - Quarterly Update and Appendix 4C
31/01/20	PRICE SENSITIVE	355.53KB	Share
IHL Quarterly Activities Update and Appendix 4C
31/01/20	PRICE SENSITIVE	355.37KB	Share
IHL Clinical Progress on IHL-42X for Obstructive Sleep Apnoea
29/01/20	PRICE SENSITIVE	172.54KB	Share
IHL Change of Share Registry
20/01/20		234.34KB	Share
IHL Change of Director's Interest Notice
07/01/20		258.52KB	Share
IHL Appendix 2A
06/01/20		118.82KB	Share
IHL Impression Sources 1,054 Patients for Incannex CBD-100 Oils
24/12/19		173.45KB	Share
IHL IHL Files Patent over IHL-42X for OSA
06/12/19	PRICE SENSITIVE	147.98KB	Share
IHL Appendix 3G
04/12/19		280.22KB	Share
IHL IHL appoints Big-Pharma expert to lead drug development
04/11/19	PRICE SENSITIVE	241.17KB	Share
IHL Quarterly Activities Report and Appendix 4C
01/11/19	PRICE SENSITIVE	361.79KB	Share
IHL Appendix 3B - Placement/Prospectus Securities
31/10/19		444.43KB	Share
IHL Cleansing Prospectus
24/10/19	PRICE SENSITIVE	400.07KB	Share
IHL IHL completes $5m capital raise
24/10/19	PRICE SENSITIVE	170.93KB	Share
IHL Trading Halt
22/10/19	PRICE SENSITIVE	349.14KB	Share
IHL Conclusion of ONE Championship Agreement
21/10/19		138.14KB	Share
IHL Results of Meeting
04/10/19		124.35KB	Share
IHL Incannex Presentation - Dr Sud Agarwal - CMO
04/10/19	PRICE SENSITIVE	6.91MB	Share
IHL AGM CEO speech
04/10/19		126.94KB	Share
IHL IHL files cannabinoid patent over IHL-216A for TBI
04/10/19	PRICE SENSITIVE	187.09KB	Share
IHL Appendix 3B - Exercise of Options
27/09/19		437.81KB	Share
IHL Appendix 3B
16/09/19		438.07KB	Share
IHL Retraction of Appendix 3B and 3Y
10/09/19		735.47KB	Share
IHL Incannex CBD Oils and Medical Advisory Appointees
05/09/19	PRICE SENSITIVE	184.01KB	Share
IHL AGM Proxy Form
04/09/19		223.63KB	Share
IHL Notice of Annual General Meeting
04/09/19		351.16KB	Share
IHL Appendix 3Y
04/09/19		192.82KB	Share
IHL Appendix 3B
04/09/19		444.5KB	Share
IHL Corporate Governance Statement - Appendix 4G
04/09/19		195.77KB	Share
IHL Annual Report to shareholders
04/09/19		1.39MB	Share
IHL Preliminary Final Report - Appendix 4E
30/08/19	PRICE SENSITIVE	1.96MB	Share
IHL First Key Appointments to Medical Advisory Board
29/08/19		178.56KB	Share
IHL Major supply agreement - Air Liquide Healthcare
27/08/19	PRICE SENSITIVE	182.53KB	Share
IHL Change in Directors' Interests - Appendix 3Y x 4
26/08/19		338.79KB	Share
IHL Appendix 3B
26/08/19		442.63KB	Share
IHL Cleansing Prospectus
22/08/19		418.92KB	Share
IHL Appendix 3B - Exercise of Options
22/08/19		435.01KB	Share
IHL Commencement of Phase 2a Sleep Apnoea Clinical Trial
13/08/19	PRICE SENSITIVE	179.17KB	Share
IHL Results of Meeting
09/08/19		124.53KB	Share
IHL Reinstatement to Official Quotation
09/08/19	PRICE SENSITIVE	212.34KB	Share
IHL Oil Supply Agreement and Brand Launch
09/08/19	PRICE SENSITIVE	282.73KB	Share
IHL Voluntary Suspension from Official Quotation
08/08/19	PRICE SENSITIVE	349.28KB	Share
IHL Trading Halt
06/08/19	PRICE SENSITIVE	436.67KB	Share
IHL Official Supplier and Research Partner - ONE Championship
02/08/19	PRICE SENSITIVE	194.6KB	Share
IHL Quarterly update and Cashflow Report
31/07/19	PRICE SENSITIVE	370.7KB	Share
IHL Final Director's Interest Notice - amendment
29/07/19		204.02KB	Share
IHL Change in Director's Interest Notice x 3
29/07/19		309.76KB	Share
IHL Dr Sud Agarwal appointed as CMO & Non-Executive Director
25/07/19	PRICE SENSITIVE	157.71KB	Share
IHL Concussion Monitoring FiTGuard - Major Territory Expansion
17/07/19	PRICE SENSITIVE	537.67KB	Share
IHL Response to ASX Price Query
15/07/19	PRICE SENSITIVE	405.44KB	Share
IHL Appendix 3B amendment
11/07/19		128.25KB	Share
IHL Appendix 3B
11/07/19		411.89KB	Share
IHL Change in substantial holding
11/07/19		2.49MB	Share
IHL Notice of General Meeting/Proxy Form
11/07/19		328.71KB	Share
IHL Update on Placement/Cleansing Prospectus
09/07/19		179.67KB	Share
IHL Cleansing Prospectus
09/07/19	PRICE SENSITIVE	221.04KB	Share
IHL Dronabinol Supply Agreement/Sleep Apnoea Trial Update
05/07/19	PRICE SENSITIVE	193.44KB	Share
IHL Successful $1.65m Placement/International Expansion
03/07/19	PRICE SENSITIVE	213.99KB	Share
IHL Trading Halt
01/07/19	PRICE SENSITIVE	337.21KB	Share
IHL Concussion research partner and supplier to Boxing Australia
28/06/19	PRICE SENSITIVE	209.76KB	Share
IHL Commencement of Phase 2a Periodontitis Clinical Trial
24/06/19	PRICE SENSITIVE	207.63KB	Share
IHL CEO Comment and Corporate Overview
11/06/19		3.17MB	Share
IHL Exclusive Concussion Monitoring FitGuard Supply Agreement
06/06/19	PRICE SENSITIVE	770.72KB	Share
IHL CBD Supply Agreement - Clinical trial Iminent
03/06/19	PRICE SENSITIVE	196.45KB	Share
IHL Trading Halt
30/05/19	PRICE SENSITIVE	203.91KB	Share
IHL Pause in Trading
30/05/19	PRICE SENSITIVE	116.99KB	Share
IHL Appendix 3B
24/05/19		407.78KB	Share
IHL Reinstatement to Official Quotation
21/05/19	PRICE SENSITIVE	212.57KB	Share
IHL Company Update - Federal Court Orders
21/05/19	PRICE SENSITIVE	1.61MB	Share
IHL Update
16/05/19		135.38KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Top Stories